Avro, a life sciences startup in Y Combinator’s current batch, is banking on a method to deliver medications to populations unable to swallow or chew — it will administer them through the skin. Starting with allergy medications, the startup is developing skin patches that release drugs commonly used in seasonal allergies for children. The patches can deliver a variety of drugs. Read More
Life sciences startup Avro aims to deliver drugs to children and the elderly through skin patches
